Literature DB >> 29760536

A Method for C2 Acylation of 1,3-Indandiones.

Brian J Larsen1, Robert J Rosano1, Thomas A Ford-Hutchinson2, Allen B Reitz2, Jay E Wrobel2.   

Abstract

The 1,3-indandione scaffold is an important structural motif used in the preparation of a large number of industrial chemical and pharmaceutical compounds. However, few approaches allow for the direct C2 acylation on these building blocks. A method was developed using DMAP and EDCI, which is mild in reactivity, covers a diverse range of carboxylic acid acylating agents, is compatible with electron releasing and withdrawing substituents on the 1,3-indandione partner, and performs well in a polar aprotic solvent (for solubility reasons) This method cleanly afforded twenty five different products in yields of 32-96%.

Entities:  

Year:  2018        PMID: 29760536      PMCID: PMC5947957          DOI: 10.1016/j.tet.2018.04.041

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  9 in total

1.  Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2).

Authors:  Eddy W Yue; C Anne Higley; Susan V DiMeo; David J Carini; David A Nugiel; Carrie Benware; Pamela A Benfield; Catherine R Burton; Sarah Cox; Robert H Grafstrom; Diane M Sharp; Lisa M Sisk; John F Boylan; Jodi K Muckelbauer; Angela M Smallwood; Haiying Chen; Chong-Hwan Chang; Steven P Seitz; George L Trainor
Journal:  J Med Chem       Date:  2002-11-21       Impact factor: 7.446

2.  Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern.

Authors:  David A Nugiel; Anup Vidwans; Anna-Marie Etzkorn; Karen A Rossi; Pamela A Benfield; Catherine R Burton; Sarah Cox; Deborah Doleniak; Steven P Seitz
Journal:  J Med Chem       Date:  2002-11-21       Impact factor: 7.446

3.  Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors.

Authors:  Thomas J Greshock; John M Sanders; Robert E Drolet; Hemaka A Rajapakse; Ronald K Chang; Boyoung Kim; Vanessa L Rada; Heather E Tiscia; Hua Su; Ming-Tain Lai; Sylvie M Sur; Rosa I Sanchez; Mark T Bilodeau; John J Renger; Jonathan T Kern; John A McCauley
Journal:  Bioorg Med Chem Lett       Date:  2016-04-09       Impact factor: 2.823

4.  A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach.

Authors:  Ciro Milite; Alessandra Feoli; Kazuki Sasaki; Valeria La Pietra; Amodio Luca Balzano; Luciana Marinelli; Antonello Mai; Ettore Novellino; Sabrina Castellano; Alessandra Tosco; Gianluca Sbardella
Journal:  J Med Chem       Date:  2015-03-10       Impact factor: 7.446

5.  Synthesis of and tautomerism in 3-acyltetramic acids.

Authors:  Yong-Chul Jeong; Mark G Moloney
Journal:  J Org Chem       Date:  2011-01-20       Impact factor: 4.354

Review 6.  The molecular diversity scope of 1,3-indandione in organic synthesis.

Authors:  Shima Asadi; Ghodsi Mohammadi Ziarani
Journal:  Mol Divers       Date:  2015-05-10       Impact factor: 2.943

7.  Isomeric solid enols on ring- and amide-carbonyls of substituted 2-carbanilido-1,3-indandiones.

Authors:  Jinhua Song; Masaaki Mishima; Zvi Rappoport
Journal:  Org Lett       Date:  2007-09-20       Impact factor: 6.005

8.  SmCl3-catalyzed C-acylation of 1,3-dicarbonyl compounds and malononitrile.

Authors:  Quansheng Shen; Wen Huang; Jialiang Wang; Xigeng Zhou
Journal:  Org Lett       Date:  2007-09-29       Impact factor: 6.005

9.  Palladium-Catalyzed Carbonylative Annulation Reactions Using Aryl Formate as a CO Source: Synthesis of 2-Substituted Indene-1,3(2H)-dione Derivatives.

Authors:  Ying Zhang; Jing-Lei Chen; Zhen-Bang Chen; Yong-Ming Zhu; Shun-Jun Ji
Journal:  J Org Chem       Date:  2015-10-20       Impact factor: 4.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.